Abstract
Fragile X syndrome is the most common heritable form of intellectual disability and is caused by the expansion over 200 repeats and subsequent methylation of the CGG triplets at the 5′ UTR of the FMR1 gene, leading to its silencing. The epigenetic and molecular mechanisms responsible for FMR1 gene silencing are not fully clarified. To identify structure-specific proteins that could recruit components of the silencing machinery we investigated the role of CGGBP1 in FMR1 gene transcription. CGGBP1 is a highly conserved protein that binds specifically to unmethylated CGG tracts. Its role on FMR1 transcription is yet to be defined. Sequencing analysis and expression studies through quantitative PCR of CGGBP1 were performed in cell lines with different allele expansions: wild type, premutation, methylated full mutation and unmethylated full mutation, demonstrating no differences between them. ChIP assays clearly demonstrated that CGGBP1 binds to unmethylated CGG triplets of the FMR1 gene, but not to methylated CGGs. We also observed that CGGBP1 binding to the FMR1 locus was restored after pharmacological demethylation, with 5-azadC, of alleles, carriers of methylated full mutation, suggesting a possible role for CGGBP1 in FMR1 expression. CGGBP1 silencing with shRNAs (reaching ~98% of CGGBP1-mRNA depletion) did not affect FMR1 transcription and CGG expansion stability in expanded alleles. Although the strong binding to the CGG tract could suggest a relevant role of CGGBP1 on FMR1 gene expression, our results demonstrate that CGGBP1 has no direct effect on FMR1 transcription and CGG repeat stability.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Pirozzi F, Tabolacci E, Neri G : The FRAXopathies: definition, overview, and update. Am J Med Genet 2011; 155A: 1803–1816.
Bassell GJ, Warren ST : Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function. Neuron 2008; 60: 201–214.
Coffee B, Keith K, Albizua I et al: Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 2009; 85: 503–514.
Crawford DC, Meadows KL, Newman JL et al: Prevalence and phenotype consequence of FRAXA and FRAXE alleles in a large, ethnically diverse, special education-needs population. Am J Hum Genet 1999; 64: 495–507.
Sutcliffe JS, Nelson DL, Zhang F et al: DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet 1992; 1: 397–400.
Pietrobono R, Tabolacci E, Zalfa F et al: Molecular dissection of the events leading to inactivation of the FMR1 gene. Hum Mol Genet 2005; 14: 267–277.
Tabolacci E, Moscato U, Zalfa F et al: Epigenetic analysis reveals a euchromatic configuration in the FMR1 unmethylated full mutations. Eur J Hum Genet 2008; 16: 1487–1498.
Darnell JC, Van Driesche SJ, Zhang C et al: FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 2001; 146: 247–261.
Smeets HJ, Smits AP, Verheij CE et al: Normal phenotype in two brothers with a full FMR1 mutation. Hum Mol Genet 1995; 4: 2103–2108.
Eiges R, Urbach A, Malcov M et al: Developmental study of fragile X syndrome using human embryonic stem cells derived from preimplantation genetically diagnosed embryos. Cell Stem Cell 2007; 1: 568–577.
Willemsen R, Bontekoe CJ, Severijnen LA et al: Timing of the absence of FMR1 expression in full mutation chorionic villi. Hum Genet 2002; 110: 601–605.
Kumari D, Usdin K : The distribution of repressive histone modifications on silenced FMR1 alleles provides clues to the mechanism of gene silencing in fragile X syndrome. Hum Mol Genet 2010; 19: 4634–4642.
Nolin SL, Sah S, Glicksman A et al: Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. Am J Med Genet 2013; 161A: 771–778.
Volle CB, Delaney S : AGG/CCT interruptions affect nucleosome formation and positioning of healthy-length CGG/CCG triplet repeats. BMC Biochem 2013; 14: 33.
Hagihara M, He H, Kimura M et al: A small molecule regulates hairpin structures in d(CGG) trinucleotide repeats. Bioorg Med Chem Lett 2012; 22: 2000–2003.
Deissler H, Wilm M, Genç B et al: Rapid protein sequencing by tandem mass spectrometry and cDNA cloning of p20-CGGBP. A novel protein that binds to the unstable triplet repeat 5′-d(CGG)n-3′ in the human FMR1 gene. J Biol Chem 1997; 272: 16761–16768.
Naumann F, Remus R, Schmitz B et al: Gene structure and expression of the 5′-(CGG)(n)-3′-binding protein (CGGBP1). Genomics 2004; 83: 106–118.
Singh U, Westermark B : CGGBP1 is a nuclear and midbody protein regulating abscission. Exp Cell Res 2011; 317: 143–150.
Singh U, Roswall P, Uhrbom L et al: CGGBP1 regulates cell cycle in cancer cells. BMC Mol Biol 2011; 12: 28.
Singh U, Maturi V, Jones RE et al: CGGBP1 phosphorylation constitutes a telomere-protection signal. Cell Cycle 2014; 13: 96–105.
Müller-Hartmann H, Deissler H, Naumann F et al: The human 20-kDa 5′-(CGG)(n)-3′-binding protein is targeted to the nucleus and affects the activity of the FMR1 promoter. J Biol Chem 2000; 275: 6447–6452.
Chiurazzi P, Pomponi MG, Willemsen R et al: In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Hum Mol Genet 1998; 7: 109–113.
Tabolacci E, Pietrobono R, Moscato U et al: Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments. Eur J Hum Genet 2005; 13: 641–648.
Pietrobono R, Pomponi MG, Tabolacci E et al: Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine. Nucleic Acids Res 2002; 30: 3278–3285.
Sinden RR : Biological implications of the DNA structures associated with disease-causing triplet repeats. Am J Hum Genet 1999; 64: 346–353.
Colak D, Zaninovic N, Cohen MS et al: Promoter-bound trinucleotide repeat mRNA drives epigenetic silencing in fragile X syndrome. Science 2014; 343: 1002–1005.
Lanni S, Goracci M, Borrelli L et al: Role of CTCF protein in regulating FMR1 locus transcription. PLoS Genet 2013; 9: e1003601.
Acknowledgements
This work was supported by Telethon grant (GGP10150), FRAXA Foundation and Italian Association for Fragile X syndrome to GN. We gratefully acknowledge Prof. Maurizio Genuardi for his critical revision of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies this paper on European Journal of Human Genetics website
Supplementary information
Rights and permissions
About this article
Cite this article
Goracci, M., Lanni, S., Mancano, G. et al. Defining the role of the CGGBP1 protein in FMR1 gene expression. Eur J Hum Genet 24, 697–703 (2016). https://doi.org/10.1038/ejhg.2015.182
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/ejhg.2015.182
